Pfizer’s German partner, BioNTech, achieves breakthrough in quest for multiple sclerosis vaccineBioNTech, the German biotechnology company that developed a coronavirus vaccine with U.S. drugmaker Pfizer, has found some success using the same mRNA technique while attempting to treat multiple sclerosis in lab mice.

read more »

More News »

Level
Story XP
Story XP
Stories
Followers